In prostate cancer, the feedback loops between these pathways is disrupted, leading to increased amounts of LDLR at the cell surface and thereby elevating uptake of LDL-derived cholesterol, altogether raising cellular cholesterol levels [16]. Here, LDLR is linked to Familial prostate cancer.